Vermillion has appointed Marra Francis as chief medical officer. Francis is a board-certified obstetrician and gynecologist. She has served as a national speaker and key opinion leader for Myriad Genetics, as national speaker for Cord Blood registries, as an "Ask the Expert" contributor at Parents.com, as a contributing physician to the Mommy MD Guide books and publications, and a medical affairs consultant for Vermillion. Francis has also served as both vice chair and chair of the Department of Obstetrics and Gynecology at Memorial Hermann The Woodlands Hospital.
OraSure Technologies has appointed Stephen Tang as chairman of its board of directors. Tang takes over from Douglas Watson, who served as chairman since March 2003. He has been a board member since April 2011, served as chairman of the compensation committee since May 2014, and is also a member of the nominating and corporate governance committee. Tang has now relinquished his position as chairman of the compensation committee, but will remain as a member of both committees while serving as chairman of the board.
Clinical Genomics has appointed Michael Dugan as its chief medical officer. Dugan previously served as president and CEO of MCDXI Medical Diagnostics, where he led clinical evaluation, strategic development and clinical education efforts for companies bringing diagnostic tests and related products to market. Before that, he was also senior vice president of clinical development and medical affairs at Exact Sciences, medical director at Quest Diagnostics' Nichols Institute, and vice president and laboratory director at Specialty Laboratories.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.